MedTrace Logo

Analgesic Effect of Pregabalin in Patients Undergoing Total Abdominal Hysterectomy

NCT01466101 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2012-02-20

No results posted yet for this study

Summary

Pregabalin will decrease the total amount of opioid required in patients undergoing total abdominal hysterectomy. In addition, pregabalin will decrease the incidence of opioid-related side effects in patients undergoing total abdominal hysterectomy.

Conditions

Interventions

DRUG

Placebo administration

Administration of placebo

DRUG

Pregabalin administration

Administration of pregabalin

Sponsors & Collaborators

Principal Investigators

  • Christian Altman, MD · Northwestern University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01466101 on ClinicalTrials.gov